Marina Konopleva
0000-0002-9347-2212
Publication & Citation Trends
Publications
0 total
Abstract 7897: Novel Rho-GTPase regulatory protein gene family variants are frequent and associate with poor survival in patients (pts) with acute myeloid leukemia (AML)
Cited by 0
Semantic Scholar
Abstract 1841: Venetoclax rewires Notch signaling to drive resistance in North American adult T-cell leukemia/lymphoma.
Cited by 0
Semantic Scholar
Differentiation-dependent EBF1 Activity Determines CD22 Transcription and Leukemia Sensitivity to Inotuzumab Ozogamicin.
Cited by 4
Semantic Scholar
Phenotypic heterogeneity and remodeling drive resistance to venetoclax treatment in acute myeloid leukemia
Cited by 0
Semantic Scholar
Pitavastatin counteracts venetoclax resistance mechanisms in acute myeloid leukemia by depleting geranylgeranyl pyrophosphate
Cited by 1
Semantic Scholar
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL. OA
Cited by 25
Semantic Scholar
Research Topics
Acute Myeloid Leukemia Research
(1046)
Chronic Myeloid Leukemia Treatments
(517)
Acute Lymphoblastic Leukemia research
(430)
Chronic Lymphocytic Leukemia Research
(318)
CAR-T cell therapy research
(242)
Affiliations
Roche (Switzerland)
Albert Einstein College of Medicine
Beth Israel Deaconess Medical Center
Valve (United States)
National Marrow Donor Program